Published in CNS Drugs on October 01, 2013
Management of alcohol dependence in patients with liver disease. CNS Drugs (2013) 2.35
Early liver transplantation for severe alcoholic hepatitis. N Engl J Med (2011) 8.50
M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology (2013) 2.16
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Hepatology (2014) 2.05
Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res (2007) 2.02
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA (2013) 1.94
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut (2010) 1.83
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology (2010) 1.82
Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci (2003) 1.78
Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis. J Hepatol (2011) 1.73
Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology (2009) 1.67
Posterior fossa volume increase after surgery for Chiari malformation Type I: a quantitative assessment using magnetic resonance imaging and correlations with the treatment response. J Neurosurg (2011) 1.62
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol (2012) 1.61
Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats. Crit Care Med (2007) 1.57
Stroke prevention: management of modifiable vascular risk factors. J Neurol (2002) 1.55
Lipid profiles and outcome in patients treated by intravenous thrombolysis for cerebral ischemia. Neurology (2012) 1.51
[Study on personality and psychiatric disorder in fibromyalgia]. Presse Med (2009) 1.47
Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol (2003) 1.32
Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid Redox Signal (2014) 1.29
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord (2008) 1.27
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One (2009) 1.25
Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function. Stroke (2003) 1.14
Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. Glycobiology (2005) 1.13
Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Neurosurgery (2007) 1.12
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Expert Rev Neurother (2009) 1.10
Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia. Br J Pharmacol (2009) 1.10
The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology (2006) 1.09
Baclofen for alcohol-dependence: anticraving or partial substitution? J Clin Psychopharmacol (2013) 1.07
Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder. Biol Psychiatry (2004) 1.07
PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology (2008) 1.04
Sexual addiction or hypersexual disorder: different terms for the same problem? A review of the literature. Curr Pharm Des (2014) 1.01
Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours. Cerebrovasc Dis (2010) 1.01
Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier. Curr Neurovasc Res (2009) 1.00
Insular infarcts and electrocardiographic changes at admission: results of the PRognostic of Insular CErebral infarctS Study (PRINCESS). J Neurol (2006) 0.99
Paullinia pinnata extracts rich in polyphenols promote vascular relaxation via endothelium-dependent mechanisms. J Cardiovasc Pharmacol (2006) 0.99
Validation of the DRAGON score in 12 stroke centers in anterior and posterior circulation. Stroke (2013) 0.98
Brain morphometry reproducibility in multi-center 3T MRI studies: a comparison of cross-sectional and longitudinal segmentations. Neuroimage (2013) 0.97
The cost of adverse drug reactions. Expert Opin Pharmacother (2003) 0.96
Pharmacological treatments for cocaine dependence: is there something new? Curr Pharm Des (2011) 0.96
Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J ECT (2010) 0.96
Postconditioning in focal cerebral ischemia: role of the mitochondrial ATP-dependent potassium channel. Brain Res (2010) 0.95
Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance. J Cereb Blood Flow Metab (2003) 0.95
NOD2: a potential target for regulating liver injury. Lab Invest (2008) 0.95
Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion. Br J Pharmacol (2005) 0.94
Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock. Intensive Care Med (2004) 0.93
Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control. Gastroenterology (2009) 0.92
Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends. Curr Pharm Des (2015) 0.92
Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not. Brain Res (2007) 0.91
SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome. Psychiatry Res (2002) 0.91
Evaluation of amantadine in chronic hepatitis C: a meta-analysis. J Hepatol (2004) 0.91
Anticipation of body-scaled action is modified in anorexia nervosa. Neuropsychologia (2010) 0.90
Brain ischemic preconditioning is abolished by antioxidant drugs but does not up-regulate superoxide dismutase and glutathion peroxidase. Brain Res (2004) 0.90
PPARs: a potential target for a disease-modifying strategy in stroke. Curr Drug Targets (2013) 0.90
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. Eur J Gastroenterol Hepatol (2011) 0.89
Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.89
IV thrombolysis and renal function. Neurology (2013) 0.89
Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke. J Neuroinflammation (2014) 0.88
Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients. Ann Pharmacother (2012) 0.87
Catatonia and liver transplant. Psychosomatics (2002) 0.87
Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection. Vascul Pharmacol (2009) 0.86
Vitamin K antagonists-associated cerebral hemorrhages: what are their characteristics? Stroke (2013) 0.86
Inversion of melatonin circadian rhythm in chronic alcoholic patients during withdrawal: preliminary study on seven patients. Alcohol Alcohol (2008) 0.86
Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease. Inflamm Bowel Dis (2009) 0.86
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial. J Neurol Neurosurg Psychiatry (2013) 0.85
Pretreatment with peroxysome proliferator-activated receptor alpha agonist fenofibrate protects endothelium in rabbit Escherichia coli endotoxin-induced shock. Intensive Care Med (2005) 0.85
Activated protein C increases sensitivity to vasoconstriction in rabbit Escherichia coli endotoxin-induced shock. Crit Care (2006) 0.85
Sleep quality and apnea in stable methadone maintenance treatment. Subst Use Misuse (2010) 0.85
Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability. Epilepsy Res (2009) 0.85
Vigilance states in a parkinsonian model, the MPTP mouse. Eur J Neurosci (2004) 0.85
Preconditioning by an in situ administration of hydrogen peroxide: involvement of reactive oxygen species and mitochondrial ATP-dependent potassium channel in a cerebral ischemia-reperfusion model. Brain Res (2008) 0.85
Experimental stroke protection induced by 4-hydroxybenzyl alcohol is cancelled by bacitracin. Neurosci Res (2009) 0.84
[In Process Citation]. Therapie (2012) 0.84
What are the causes of pre-existing dementia in patients with intracerebral haemorrhages? Brain (2010) 0.84
Catatonia and alcohol withdrawal: a complex and underestimated syndrome. Alcohol Alcohol (2012) 0.84
Brain ischemia changes the long term response to antidepressant drugs in mice. Behav Brain Res (2011) 0.84
Spatial orientation constancy is impaired in anorexia nervosa. Psychiatry Res (2011) 0.84
Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive properties. Epilepsia (2008) 0.83
The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunction. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.83
Previous leisure-time physical activity dose dependently decreases ischemic stroke severity. Stroke Res Treat (2011) 0.82
Increased susceptibility of low-density lipoprotein to ex vivo oxidation in mice transgenic for human apolipoprotein B treated with 1 melatonin-related compound is not associated with atherosclerosis progression. J Cardiovasc Pharmacol (2005) 0.82
Fetal alcohol-induced hyperactivity is reversed by treatment with the PPARα agonist fenofibrate in a rat model. Psychopharmacology (Berl) (2010) 0.82
Peroxisome proliferator-activated receptors in HBV-related infection. PPAR Res (2009) 0.82
MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations. Exp Brain Res (2008) 0.82
Catatonia and systemic lupus erythematosus: a clinical study of three cases. Gen Hosp Psychiatry (2008) 0.82
Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder. J Clin Psychopharmacol (2014) 0.82
Imagining one's own and someone else's body actions: dissociation in anorexia nervosa. PLoS One (2012) 0.82
Pharmacology of Alzheimer's disease: appraisal and prospects. Dement Geriatr Cogn Disord (2005) 0.81
Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice. J Sleep Res (2008) 0.81
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl (2007) 0.81
Influence of differences in case mix on the better outcome of smokers after intravenous thrombolysis for acute cerebral ischemia. Eur Neurol (2012) 0.81
Self-mutilation induced by cocaine abuse: the pleasure of bleeding. Presse Med (2006) 0.81
The strange case of Dr HDL and Mr HDL: does a NO's story illuminate the mystery of HDL's dark side uncovered by Dr HDL's drug targeting CETP? Med Hypotheses (2007) 0.80
Corticosteroid-induced psychiatric episodes in consultation liaison psychiatry. Personality and temperament assessments. Presse Med (2010) 0.80
Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease. Behav Pharmacol (2010) 0.80
Treatment of severe forms of alcoholic hepatitis: where are we going? J Gastroenterol Hepatol (2008) 0.80
The PPARα Agonist Fenofibrate Reduces Prepulse Inhibition Disruption in a Neurodevelopmental Model of Schizophrenia. Schizophr Res Treatment (2012) 0.80
Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients. Proteomics Clin Appl (2010) 0.80